EW Scripps backs Ebyline’s $1.5m series A round.
Month: November 2010
Fidelity drives into RedHill Pharma
Fidelity Biosciences joins consortium for RedHill Biopharma.
Clearwire searches for next year’s funding
Intel-backed wireless communications company Clearwire says its $1.38bn in cash unlikely to be enough for the next 12 months’ expenses.
Neustar buys IDG-backed Quova
Founded in 1999, Quova has raised about $38m from a consortium including IDG Ventures, and is now selling up to Neustar, news provider VentureBeat said.
Insurers select Capson Physicians
BlueCross BlueShield Venture Partners was joined in Capson’s initial $13.5m round by Beazley Investments, a subsidiary of Lloyds of London insurer Beazley, news provider American-Statesman said.
CEOs call for $1bn clean energy fund
Ratan Tata, chairman of India-based conglomerate Tata Group, and David Cote, executive chairman of US peer Honeywell, lead forum calling for $1bn clean energy fund.
Comcast cheers for SB Nation result
All Things Digital reveals SB Nation has raised $10.5m in its series C round.
Starr joins Vascular Pathways
Eugene Starr joins Vascular Pathways as executive president.
Lilly buys first venturing unit company
Lilly Ventures had been part of consortium investing about $70m in Avid Radiopharmaceuticals, which is now being acquired by Eli Lilly for up to $800m.
Hearst’s Gazillion gains further $60m
Singapore’s sovereign wealth fund Temasek led the $60m round for Gazillion Entertainment, a developer of massively multiplayer online games formerly known as NR2B Research backed by publisher Hearst.
Vericare adds debt for deal
Vericare is backed by Aetna Ventures, the corporate venturing division of healthcare provider Aetna, and is raising debt to bolt on peer.
Nexant adds further to its round
Intel Capital one of the investors in Nexant, a US-based provider of energy software and services.
Cisco prepares India opportunity
Cisco Systems prepares $200m investment in India
Nortel sells portfolio
Credit Suisse and Willowridge Partners buy Nortel Networks’ stakes in venture capital.